Recombinant full-length parathyroid hormone (1-84): A viewpoint by David Hosking

Drugs

Volumn 66, Issue 18, 2006, Pages 2382-

  Hosking, David ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PARATHYROID HORMONE[1-34]; RECOMBINANT PARATHYROID HORMONE;

BONE DEVELOPMENT; CARCINOGENICITY; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG SYNTHESIS; FOOD AND DRUG ADMINISTRATION; HUMAN; HYPERCALCEMIA; MENOPAUSAL SYNDROME; NONHUMAN; NOTE; POSTMENOPAUSE OSTEOPOROSIS; PROMOTER REGION; TREATMENT DURATION;

EID: 33846078662     PISSN: 00126667     EISSN: 00126667     Source Type: Journal    
DOI: 10.2165/00003495-200666180-00011     Document Type: Note

References (0)